Hikal Ltd (HIKAL)
₹220.76
Price history
Hikal is a partner to companies in the Pharmaceuticals, Crop Protection, and Specialty Chemicals industry. The company is in the business of supplying research services, active ingredients and intermediates for its customers. Hikal's manufacturing facilities have been inspected and approved by leading multinational companies in the Crop protection and Pharmaceutical sectors. The Crop protection facilities are located at Taloja and Mahad {Maharashtra). The Pharmaceutical manufacturing facilities are situated in Jigani (Bengaluru) and Panoli (Gujarat). Hikal's R & D facilities are located in Pune. [1]
Financials
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 434.88 | 447.50 | 514.10 | 406.80 | 452.90 | 447.70 | 552.40 | 380.40 | 318.50 | 494.30 | 519.40 | 402.80 | 434.20 | |
| YoY Sales growth | -22.17% | -17.16% | -5.72% | +4.85% | +4.14% | +0.04% | +7.45% | -6.49% | -29.68% | +10.41% | -5.97% | +5.89% | +36.33% | |
| Expenses | 377.36 | 382.80 | 419.70 | 348.80 | 378.00 | 375.60 | 429.00 | 355.30 | 311.30 | 411.60 | 414.00 | 365.80 | 389.30 | |
| Operating Profit | 57.52 | 64.70 | 94.40 | 58.00 | 74.90 | 72.10 | 123.40 | 25.10 | 7.20 | 82.70 | 105.40 | 37.00 | 44.90 | |
| OPM % | 13.23% | 14.46% | 18.36% | 14.26% | 16.54% | 16.10% | 22.34% | 6.60% | 2.26% | 16.73% | 20.29% | 9.19% | 10.34% | |
| Other Income | 0.99 | 0.10 | 0.50 | 0.50 | 0.40 | 3.60 | 0.50 | 1.00 | 1.90 | -35.20 | -40.50 | 10.70 | 1.70 | |
| Interest | 13.08 | 14.20 | 15.30 | 19.80 | 18.80 | 18.70 | 17.90 | 17.10 | 14.90 | 15.50 | 14.60 | 14.90 | 13.40 | |
| Depreciation | 28.57 | 29.00 | 32.30 | 31.80 | 31.70 | 33.20 | 37.70 | 39.40 | 41.20 | 41.20 | 42.00 | 42.70 | 41.70 | |
| Profit before tax | 16.86 | 21.60 | 47.30 | 6.90 | 24.80 | 23.80 | 68.30 | -30.40 | -47.00 | -9.20 | 8.30 | -9.90 | -8.50 | |
| Tax % | 25.44% | 25.46% | 28.33% | 26.09% | 26.21% | 27.73% | 26.50% | -26.32% | -25.74% | -35.87% | -73.49% | -25.25% | -28.24% | |
| Net Profit | 12.57 | 16.10 | 33.90 | 5.10 | 18.30 | 17.20 | 50.20 | -22.40 | -34.90 | -5.90 | 14.40 | -7.40 | -6.10 | |
| EPS in Rs | 1.02 | 1.31 | 2.75 | 0.41 | 1.48 | 1.39 | 4.07 | -1.82 | -2.83 | -0.48 | 1.17 | -0.60 | -0.49 | |
| Raw PDF |
Earnings
Results dates & reactionsFresh quarters land in the Financials table above, tagged NSE until screener catches up.
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Sep 2026Peers
8 companies| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma.Inds. | ₹1,880.00 | 36.66 | 4,51,075 | 0.85% | 1,995 | −10.53% | 16,199 | +11.88% | 20.53% |
| Divi's Lab. | ₹11,442.00 | 88.89 | 3,03,749 | 0.26% | 1,127 | +63.57% | 3,676 | +35.40% | 21.97% |
| Torrent Pharma. | ₹4,670.00 | 81.82 | 1,77,632 | 0.81% | 534 | −10.03% | 4,979 | +50.79% | 15.19% |
| Laurus Labs | ₹2,424.00 | 97.75 | 1,30,972 | 0.08% | 436 | +126.43% | 2,206 | +33.44% | 17.76% |
| Zydus Lifesci. | ₹1,189.90 | 26.20 | 1,18,693 | 0.08% | 928 | −27.96% | 7,910 | +29.17% | 21.14% |
| Dr Reddy's Labs | ₹1,380.00 | 41.17 | 1,15,267 | 0.58% | 913 | −31.35% | 8,698 | −1.48% | 13.04% |
| Cipla | ₹1,391.80 | 36.21 | 1,12,442 | 0.93% | 852 | −35.05% | 7,404 | −2.44% | 15.49% |
| Hikal | ₹222.47 | 38.53 | 2,743 | 0.27% | −6 | +82.52% | 434 | +36.33% | 3.50% |
| Median: 160 Co. | ₹465.83 | 33.99 | 2,012 | 0.08% | 13 | +33.53% | 179 | +20.92% | 14.94% |






